Item 1A. Risk Factors

There have been no material changes to the risk factors as previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(dollars in thousands, except per share data)

We had three share repurchase authorizations outstanding during the quarter ended March 31, 2022. On August 4, 2021, November 3, 2021 and February 16, 2022, we publicly announced that our Board of Directors authorized the repurchase of our outstanding common stock in one or more open market and/or privately negotiated transactions, up to an aggregate of $500,000 per authorization. The repurchase authorizations do not have expiration dates. We repurchased the following shares of our common stock during the first quarter of 2022:


Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
January 1 - 31, 2022	56,898	$	5,396.33	56,898	$	201,003
February 1 - 28, 2022	40,511	$	5,139.28	40,511	$	492,805
March 1 - 31, 2022	48,645	$	4,801.13	48,645	$	259,254
Total (1)	146,054	$	5,126.79	146,054

(1) Of the 146,054 shares repurchased during the quarter ended March 31, 2022, 1,398 outstanding shares were repurchased under the August authorization, 94,572 outstanding shares were repurchased under the November authorization, and the remaining 50,084 outstanding shares were repurchased under the February authorization. The August and November authorizations have been fully utilized as of March 31, 2022.

Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits